Skip to main content
12 November 2026
05 September 2024

Astellas Unveils New Life Sciences Center in US , Creating New Job Opportunity

Astellas Pharma Inc. officially opened its new Astellas Life Sciences Center (ALSC) in Cambridge, Mass., which will accelerate the company's efforts to create an innovation network across the state, connecting leading incubators, ambitious biotechnology start-ups and academia to foster the discovery and development of…

05 September 2024

Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business

Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, intends to acquire TTP Group ("TTP"), a leading firm in consulting and engineering for the pharmaceutical and chemical industry in Europe. TTP's portfolio encompasses a wide range of engineering services, from feasibility studies,…

30 August 2024

Medicilon Expands Global Presence with Official Opening of R&D Center in Massachusetts

In August 2024, Medicilon USA Corp (Medicilon) officially commenced operations at its second R&D center in Massachusetts, USA. Research at the new facility will focus on animal models for PK/PD and toxicology studies. This milestone heralds Medicilon's continued global business expansion. Medicilon aims to enhanc…

19 August 2024

Insulet Pharma Opens Manufacturing Facility in Malaysia

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod  brand of products, hosted a grand opening celebration at its new manufacturing facility in Johor Bahru, Malaysia. “Insulet’s remarkable growth is driven by our market-leading Omnipod 5, the first and only tubeless automated i…

08 August 2024

Parse Biosciences Partners with Taiwan-based Prisma Biotech to Extend Reach in Asia

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced an agreement with Taipei-based Prisma Biotech to broaden Parse’s reach in Taiwan and across Asia-Pacific. “Biotech, pharma, and academic researchers across Asia are boosting demand for Parse’s Evercode single …

08 August 2024

Cipla EU to invest EUR 3 million in Ethris to develop mRNA-based therapies

Cipla Limited announced that its wholly-owned subsidiary in United Kingdom, Cipla (EU) Limited will invest an additional EUR 3 million in Ethris GmbH (“Ethris”), a global leader in delivering mRNAs directly to the respiratory system. This additional investment through a convertible loan will accelerate Cipla’s partici…

Page 37 of 63

slot gacor